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0 The Journal of Thoracic and Cardiovn a characteristically bold, yet bald, attempt to preserve priority in investigative
inquiry, The Journal of Thoracic and Cardiovascular Surgery has, in this issue,
disinterred an observation first introduced four centuries ago by Macbeth: “The
ime has been, that when the brains were out, the man would die, and there an end;
ut now they rise again . . . .”1 The transplantation community is now capable
cooping out your standard donor like a canoe. Thirty different tissue varieties can
e successfully restored into welcoming recipients for years of effective function-
ng. Dying itself is, however, complex. We have evolved to avoid death. Dying
rovokes a constellation of signals that influence organ function in a receptor-
ependent fashion. Receptor expression is gene controlled, and genome-wide scan-
ing has confirmed high heritability correlating with the Framingham Heart S2
s that great American philosopher Mae West once observed, “Too much of a good
hing is wonderful.” The editor of the Journal, himself no foreigner to stress, has
ollaborated in studies documenting altered myocardial gene expression and car-
iotoxicity related to the death-induced surge in catecholamines.3,4 In this issue o
he Journal of Thoracic and Cardiovascular Surgery, Stoica and colleagues5 have
xtended these observations to the human-donor right ventricle. With apologies to
ae West, too much of a time-tested, life-preserving survival strategy can prove
ardiotoxic to a surgical transplantation intervention never imagined by Darwin.
eh and colleagues3 reported that sympathetic blockade can attenuate brain-dea
nduced cardiotoxicity. Indications for perioperative beta-blockade are expanding
apidly.6 As organ donor husbandry gains in sophistication, an additional indic
or prophylactic beta-adrenergic blockade may surface. The study by Stoica and
olleagues5 represents an important additional step in our understanding of
ormidable, multicomponent neurocardiac interface during death.
The authors5 appropriately note that the donor-selection criteria for cardiac t-
lantation remain imperfect, and that despite conscientious and careful evaluation by
ardiologists and surgeons, we continue to encounter transplanted hearts with early
ysfunction and to occasionally reject hearts that could provide long-term cardiovascu-
ar support. The authors evaluated 33 consecutive heart donors and compared their right
entricular pressure-volume loops, dopamine-stimulated contractile reserve, and slope
f the end-systolic pressure-volume relationship with those of 10 patients undergoing
oronary artery bypass surgery. Taking advantage of this kind of clinical opportunity is
he best possible kind of clinical investigation. The authors contend that experimental
nd clinical data indicate that “brain death” predominantly influences the right ventricle.
herefore, they subjected potential donor hearts to load-independent strategies of right
entricular evaluation. Although the donor hearts exhibited a higher cardiac index than
he controls who underwent coronary artery bypass graft surgery, they also displayed
mpaired load-independent indices. One might anticipate that an increased right ven-
ricular stroke volume (as identified in the donor hearts) would translate into an ejection
raction that was also increased. Clearly, the end-diastolic volume in the donor hearts
ust be even greater than the increased stroke volume. Similarly, the slope of the
nd-systolic pressure volume relationship was significantly reduced in the brain-dead
onor hearts. As predicted from the discordance between the increased right ventricular
troke volume and the compromised ejection fraction, the right ventricular end-diastolic
olume index was higher. These hearts did exhibit some contractile reserve in that they
esponded to dopamine with an increased cardiac output; however, this further increased
ascular Surgery ● July 2006
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Lhe right ventricular end-diastolic volume. Perhaps predictably,
onor hearts that already exhibited an increased right ventric-
lar end-diastolic volume also demonstrated early postopera-
ive dysfunction. Thus, the authors identified increased right
entricular end-diastolic volume as a predictor of postcardiac
ransplantation trouble. The authors suggest that brain death
rovokes right ventricular dysfunction and that this may go
ndetected with conventional techniques. The authors suggest
refinement of selection criteria to include load-independent
ndices of performance.” It seems that this might significantly
omplicate the evaluation of these already unstable patients. It
ould be valuable for the authors to identify “standard criteria”
or donor acceptability and then relate these criteria to pre-
arvest right ventricular volumes with an accompanying rela-
ionship between right ventricular end-diastolic volume and
uccessful cardiac function posttransplantation. The authors
ake the persuasive case that they have identified an important
redictor of donor acceptability. It would also be valuable to
ssess the number of potential donors who are acceptable by
standard criteria” and subsequently exhibit posttransplanta-
ion “trouble” that might have been predicted by the “right
entricular end-diastolic volume index.” Similarly, it would be
aluable for the authors to estimate the number of donorsdoi:10.1016/j.jtcvs.2006.05.021
The Journal of Thoracf right ventricular volume/function evaluations might identify
hem as “acceptable.”
We must admire Stoica and colleagues5 for persistently
hipping away at the intimidating complexities of the neu-
ocardiac axis. We are making progress, but our brains are
omplex. As observed by Emerson Pugh: “If the human
rain were so simple that we could understand it; we would
e so simple that we couldn’t.”
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Notices of Correction
Galetta D, Cesario A, Margaritora S, Porziella V, Piraino A, D’Angelillo RM, Gambacorta MA,
Ramella S, Trodella L, Valente S, Corbo GM, Macis G, Mulè A, Cardaci V, Sterzi S, Granone P,
Russo P. Multimodality treatment of unresectable stage III non–small cell lung cancer: Interim
analysis of a phase II trial with preoperative gemcitabine and concurrent radiotherapy. J Thorac
Cardiovasc Surg. 2006;131:314-21.
The institutional affiliation for Dr. Patrizia Russo is incorrect. Her correct affiliation is Transla-
tional Research B (Lung), Department of Integrated Medical Oncology (DOMI), National Cancer
Institute, Genova, Italy.
Bodnar E, Blackstone EH. An “actual” problem: Another issue of apples and oranges. J Thorac
Carrdiovasc Surg. 2006;131:1-3.
In the January 2006 issue of the Journal, the article contained a lengthy discussion relating to the
appropriate use of Kaplan-Meier event estimates versus use of “actual” event data. The statement that
the Journal will no longer accept articles using “actual” event rates to describe prosthesis longevity
was not meant to be included because this approach remains a source of controversy. The Journal will
allow the author’s discretion as to which event descriptor is most appropriate but reserves the right to
subject such articles to statistical review rather than applying an arbitrary standard.
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